AYTU Earnings AYTU BIOPHARMA, INC
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q3 2026 | 2026-03-31 | -1.42 | 2026-05-13 | 10-Q |
| Q2 2026 | 2025-12-31 | -0.89 | 2026-02-03 | 10-Q |
| Q1 2026 | 2025-09-30 | -0.08 | 2025-11-13 | 10-Q |
| Q3 2026 | 2025-03-31 | -0.22 | 2026-05-13 | 10-Q |
| Q2 2026 | 2024-12-31 | -0.41 | 2026-02-03 | 10-Q |
| Q1 2026 | 2024-09-30 | -0.15 | 2025-11-13 | 10-Q |
| Q3 2025 | 2024-03-31 | -2.04 | 2025-05-14 | 10-Q |
| Q2 2025 | 2023-12-31 | -1.52 | 2025-02-12 | 10-Q |
| Q1 2025 | 2023-09-30 | -1.48 | 2024-11-13 | 10-Q |
| FY 2023 | 2023-06-30 | -5.11 | 2023-10-12 | 10-K |
| Q3 2023 | 2023-03-31 | -4.71 | 2023-05-11 | 10-Q |
| Q2 2023 | 2022-12-31 | -2.62 | 2023-02-21 | 10-Q |
| Q1 2024 | 2022-09-30 | -0.28 | 2023-11-14 | 10-Q |
| FY 2023 | 2022-06-30 | -74.01 | 2023-10-12 | 10-K |
| Q3 2023 | 2022-03-31 | -68.13 | 2023-05-11 | 10-Q |
| Q2 2023 | 2021-12-31 | -30.30 | 2023-02-21 | 10-Q |
| Q1 2023 | 2021-09-30 | -1.09 | 2022-11-14 | 10-Q |
| FY 2022 | 2021-06-30 | -3.48 | 2022-09-27 | 10-K |
| Q3 2022 | 2021-03-31 | -2.71 | 2022-05-16 | 10-Q |
| Q2 2022 | 2020-12-31 | -1.09 | 2022-02-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.